Classification system of complications in neuroleptic malignant syndrome

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 3, 1997, Pages 193-199

  Taniguchi, Norio ^a   Tanii, Hisashi ^a   Nishikawa, Takashi ^a   Miyamae, Yasuyuki ^a   Shinozaki, Kazuhiro ^a   Inoue, Yoichi ^a   Morihara, Takashi ^a   Nakano, Yuka ^a   Nishimura, Tsuyoshi ^b   Takeda, Masatoshi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KOSHIEN UNIVERSITY   (Japan)

Author keywords

Acute renal failure; Creatine phosphokinase; Neuroleptic malignant syndrome; Respiratory disturbance

Indexed keywords

CREATINE KINASE;

ACUTE KIDNEY FAILURE; ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PROGNOSIS; RESPIRATORY DISTRESS; RHABDOMYOLYSIS;

ADOLESCENT; ADULT; BIOPSY; CREATINE KINASE; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; RESPIRATION DISORDERS; RHABDOMYOLYSIS; SEVERITY OF ILLNESS INDEX;

EID: 8544226227     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Delay, J., Pichot, P., Lempériére, T., Elissalde, B., Peigne, F. Un neuroleptique majeur non phénothiazinique et non réserpinique, l'hálopéridol, dans le traitement des psychoses. Ann Med Psychol 1960, 118: 145-52.
2. Becker, B.N., Ismail, N. The neuroleptic malignant syndrome and acute renal failure. J Am Soc Nephrol 1994, 4: 1406-12.
3. Johnson, M.D., Newman, J.H., Baxter, J.W. Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation. South Med J 1988, 81: 543-5.
4. Lenler-Peterson, P., Hansen, B.D., Hasselstrom, L. A rapidly progressing lethal case of neuroleptic malignant syndrome. Intensive Care Med 1990, 16: 267-8.
5. Mueller, P.S. Neuroleptic malignant syndrome. Psychosomatics 1984, 26: 654-62.
6. Velamoor, V.R., Norman, R.M.G., Caroff, S.N., Mann, S.C., Sullivan, K.A., Antelo, R.E. Progression of symptoms in neuroleptic malignant syndrame. J Nerv Ment Dis 1994, 182: 168-73.
7. Adityanjee, Singh, S., Singh, G., Susan, O. Spectrum concept of neuroleptic malignant syndrome. Br J Psychiatry 1988, 153: 107-11.
8. Adityanjee. The myth of elevated serum creatine phospkokinase level and neuroleptic malignant syndrome. Br J Psychiatry 1990, 158: 706-7.
9. Kallmeyer, J.C., Macsearraigh, E.T. Changes in calcium levels associated with rhabdomyolysis-induced acute renal failure. South Afr Med J 1982, 62: 810-1.
10. Bell, W.R. Disseminated intravascular coagulation. John Hopkins Med J 1980, 148: 289-99.
11. Ohta, T., Waga, S., Handa, H. et al. New grading of level of disordered consciousness. No-Shinkei-Geka 1974, 2: 623-7.
12. Coons, D.J., Hillman, F.J., Marshall, R.W. Treatment of neuroleptic malignant syndrome with dantrolene sodium: A case report. Am J Psychiatry 1982, 139: 944-5.
13. Zubenko, G., Pope, H.G. Management of a case ofneuroleptic malignant syndrome with bromocriptine. Am J Psychiatry 1983, 140: 1619-20.
14. Barkin, R.L., Stein, Z.L.G. Comment: Neuroleptic malig-nant syndrome. Drug Intell Clin Pharm 1985, 19: 211.
15. Perchik, J.S., Winkelsteh, A., Schadduck, R.S. Disseminated intravascular coagulation in heat stroke. JAMA 1975, 231: 480-3.
16. Taniguchi, N., Kagomoto, T., Matsunaga, H., Inui, M. Three cases of neuroleptic malignant syndrome complicated with DIC and ARF, those were treated as outpatients in summer-time by neuroleplic medications. Clin Psychiatry 1992, 34: 1209-16.
17. Anderson, S.H., Weinschenk, K. Peripheral neuropathy as a component of the neuroleptic malignant syndrome. Am J Med 1987, 82: 169-70.
18. Lazarus, A. Should neuroleptic malignant syndrome be treated in a private psychiatric hospital or a general hospital. Gen Hosp Psychiatry 1990, 12: 245-7.